THOMAS MONATH PROFILE:
Riding the Biodefense Wave
Martin Enserink
CAMBRIDGE, MASSACHUSETTS--An infectious disease researcher-turned-entrepreneur has used strong scientific credentials, an aversion to risk, a stroke of luck, and enviable connections to turn a company on the verge of collapse into a profitable producer of biodefense vaccines.